NCT03789253View on ClinicalTrials.gov

Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

July 31, 2030

Study Completion Date

July 31, 2030

Conditions
Prostate Cancer Stage I
Trial Locations (1)

10002

RECRUITING

National Taiwan University, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER